Characterization of TIMP-3 in human articular talar cartilage

被引:27
作者
Morris, Kirsten J. [1 ]
Cs-Szabo, Gabriella [1 ]
Cole, Ada A. [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA
关键词
TIMP-3; glycosaminoglycans; perlecan; syndecan; cartilage; extracellular matrix; TRANSFORMATION-SENSITIVE PROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; CHICKEN-EMBRYO FIBROBLASTS; HUMAN TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; GENE FAMILY; TGF-BETA; METALLOPROTEINASES (TIMP)-3; EXPRESSION; IDENTIFICATION;
D O I
10.3109/03008201003686958
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Tissue inhibitor of matrix metalloproteinase 3 (TIMP-3) is an inhibitor of matrix degradation; however, little else is known about the role(s) of this protein in articular cartilage. In this study we compared levels of TIMP-3 in human knee and ankle cartilages and in normal and degraded cartilages. In addition, our studies focused on the compartmentalization of TIMP-3 in human adult articular cartilage matrix, identification of its potential binding partners, and determining the effects of cytokines on its matrix compartment deposition. We extracted TIMP-3 from cartilage and found that while TIMP-3 was localized throughout the matrix, it was predominately associated with the chondrocyte. We also found that more TIMP-3 was extracted from normal compared to degraded cartilage and more in ankle than knee cartilage suggesting the potential of this inhibitor as a protective agent. Our data suggest that TIMP-3 interacts with heparan sulfate and heparan sulfate proteoglycans and to a lesser extent with heparin and chondroitin sulfate. Stimulation with Interleukin-1 beta and osteogenic protein-1 decreased while tumor necrosis factor alpha and transforming growth factor beta increased TIMP-3 protein levels; however, TIMP-3 mRNA was not significantly affected by any of these treatments. These characteristics indicate the chondroprotective nature of TIMP-3 and its potential as a therapeutic agent for osteoarthritis.
引用
收藏
页码:478 / 490
页数:13
相关论文
共 40 条
[1]
TNF-α converting enzyme (TACE) is inhibited by TIMP-3 [J].
Amour, A ;
Slocombe, PM ;
Webster, A ;
Butler, M ;
Knight, CG ;
Smith, BJ ;
Stephens, PE ;
Shelley, C ;
Hutton, M ;
Knäuper, V ;
Docherty, AJP ;
Murphy, G .
FEBS LETTERS, 1998, 435 (01) :39-44
[2]
AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
[3]
THE GENE STRUCTURE OF TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP)-3 AND ITS INHIBITORY ACTIVITIES DEFINE THE DISTINCT TIMP GENE FAMILY [J].
APTE, SS ;
OLSEN, BR ;
MURPHY, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14313-14318
[4]
TRANSFORMATION-SENSITIVE PROTEIN ASSOCIATED WITH THE CELL SUBSTRATUM OF CHICKEN-EMBRYO FIBROBLASTS [J].
BLENIS, J ;
HAWKES, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (03) :770-774
[5]
BLENIS J, 1984, J BIOL CHEM, V259, P1563
[6]
Issue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes [J].
Borland, G ;
Murphy, G ;
Ager, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) :2810-2815
[7]
Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[8]
Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage [J].
Davidson, Rose K. ;
Waters, Jasmine G. ;
Kevorkian, Lara ;
Darrah, Clare ;
Cooper, Adele ;
Donell, Simon T. ;
Clark, Ian M. .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
[9]
High binding capacity of cyclophilin B to chondrocyte heparan sulfate proteoglycans and its release from the cell surface by matrix metalloproteinases - Possible role as a proinflammatory mediator in arthritis [J].
De Ceuninck, F ;
Allain, F ;
Caliez, A ;
Spik, G ;
Vanhoutte, PM .
ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2197-2206
[10]
Human knee and ankle cartilage explants: catabolic differences [J].
Eger, W ;
Schumacher, BL ;
Mollenhauer, J ;
Kuettner, KE ;
Cole, AA .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2002, 20 (03) :526-534